Friday, October 2, 2026
26.3 C
Bengaluru

DigiStorm 2018: Intent, Content, Strategy and Skills

[su_dropcap style="flat"]T[/su_dropcap]he pharma industry in India is entering a very interesting variant of the post-digital marketing era. The term “post-digital marketing” is used to depict a state where the lines between physical and digital blur considerably for a customer. However, in the context of pharma, this means a state where the industry has stopped questioning the need for digital and has begun to implement very interesting digital marketing initiatives.

DigiStorm has always been about practising managers sharing their successes and failures and the lessons learned from them, than about theory and concepts.

At DigiStorm 2018 in Bengaluru, the sessions were lined up to explore how pharma is dealing with the post-digital marketing world. DigiStorm has always been about practising managers sharing their successes and failures and the lessons learned from them, than about theory and concepts. Built on a framework of Intent, Content, Strategy and Skills – DigiStorm hosted several CEOs, VPs, BU heads and Marketing/Sales heads who not only shared their experiences on the dais but also comprised the large audience that benefited from the discussions.

Competing Successfully in the Digital Economy

Following on from the highly interactive and eventful CEO Round Table which established the need for top-down engagement and involvement of the C-suite in an organization’s journey into technology and transformation, the second session dealt with VP-Marketing and BU Heads discussing their ‘on-the-ground’ experiences in taking the CEO’s vision forward in terms of execution.

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

Why Is the World’s Pharmacy Failing to Protect Patients from Harm?

This MedicinMan Intelligence Report follows a disturbing trail—from Arun...

Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.

With over three decades of experience in the pharmaceutical...

The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?

India’s anaemia challenge is not simply about access to...

10 Years of Pharma M&A — Who’s Really Benefited?

Pharmaceutical M&A is usually discussed in the language of...

What’s Killing Patients? Cancer or Rigged Drug Prices?

The disease is real. So is the markup. Confusing...

Topics

Why Is the World’s Pharmacy Failing to Protect Patients from Harm?

This MedicinMan Intelligence Report follows a disturbing trail—from Arun...

10 Years of Pharma M&A — Who’s Really Benefited?

Pharmaceutical M&A is usually discussed in the language of...

What’s Killing Patients? Cancer or Rigged Drug Prices?

The disease is real. So is the markup. Confusing...

A Tale of Two Cities: Peptides and Prescriptions

What our health choices reveal about education, access and...

Trust Is Pharma’s Fulcrum: Are We Getting the Basics Right?

MedicinMan Intelligent Insights When Air India CEO Tewolde Gebremariam...
spot_img

Related Articles

spot_imgspot_img